Regulatory News
Wednesday, June 29, 2016
BRIEF-UK's CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe
* UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of
MASTA and Sangers to a Phase 2 investigation.
Source text for Eikon: (http://bit.ly/29eSv3J)
(Bengaluru...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment